Aequi Acquisition Corp.
ARBGW
NASDAQ Capital Market0.00
USD
+0.00
- -
Aequi Acquisition Corp.
ARBGW
(NASDAQ Capital Market)
Recent
price
0.00
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Aequi Acquisition Corp. (ARBGW) operates as a blank check company whose purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, with a focus on the healthcare industry including biopharmaceuticals, medical devices, diagnostics, life science tools and healthcare services sectors in the United States and internationally; it offers no other products or services. Incorporated in 2020 and headquartered in Greenwich, Connecticut, the company targets businesses with potential for long-term growth and value creation. In July 2023, Aequi Acquisition Corp. announced its intent to liquidate after failing to complete an initial business combination by the August 24, 2023 deadline, redeeming all outstanding Class A common shares at approximately $10.25 per share on or after August 3, 2023, delisting from Nasdaq via Form 25 and terminating reporting obligations with Form 15; warrants (ARBGW) expired worthless and the entity is now liquidated with no ongoing operations.